According to recently compiled data by WHO, worldwide approximately 150 million people have diabetes mellitus, and this number is expected to be doubled by the year 2025
Natural products have long been used in traditional systems of medicine for diabetes. A number of them have gained universal appeal due to their safety and efficacy profile that have been evaluated using modern scientific techniques.
Inhibition of sodium–glucose co-transporter is a novel therapeutic approach to control diabetes, which is considered as a prominent change with respect to diabetes treatment options.
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa’s mission is to provide evidence-based natural products for human functional nutrition and well-being.
Over the past 30 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products.